Autor: |
Saemian, Nader, Shirvani, Gholamhossein, Oliyaee, Sayed, Javaheri, Mohsen |
Předmět: |
|
Zdroj: |
Journal of Radioanalytical & Nuclear Chemistry; Apr2012, Vol. 292 Issue 1, p237-241, 5p, 3 Diagrams |
Abstrakt: |
The key synthetic intermediate, (2-mercapto-1-(4-nitrobenzyl)-1H-imidazol-5-yl)methanol-[2-C], has been synthesized by using one pot procedure from potassium[C]-thiocyanate. It was converted to two nonpeptide angiotensin II receptor antagonists, 2-methylthio-1-[4-N-α-ethoxycarbonyl benzyl)-aminobenzyl]-5-hydroxymethyl-1H-imidazole-[2-C] and 1-[4-N-α-ethoxy-carbonylbenzyl)-aminobenzyl]-5-hydroxymethyl-1H-imidazole-[2-C] via a 3-step sequence synthetic pathway. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|